Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Tizanidine Extension in MS Spasticity
NCT00464958Phase 2Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tizanidine in spasticity, sponsored by Teva Pharmaceutical Industries Ltd.. Started Jan 2008; status: terminated.
02
Drugs
tizanidine
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT00464958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464958.